Quick Answer
Pharma-Bio Serv, Inc. reported Gross Profit of $2.91 million for fiscal year 2025.
Pharma-Bio Serv, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $2.91M | +15.7% |
| 2024 | $2.52M | -50.3% |
| 2023 | $5.07M | +3.8% |
| 2022 | $4.88M | -8.9% |
| 2021 | $5.36M | -19.6% |
| 2020 | $6.67M | +7.9% |
| 2019 | $6.18M | +8.6% |
| 2018 | $5.69M | +48.0% |
| 2017 | $3.84M | -33.6% |
| 2016 | $5.78M | -22.7% |
| 2015 | $7.48M | -16.6% |
| 2014 | $8.97M | -24.2% |
| 2013 | $11.83M | +19.9% |
| 2012 | $9.87M | +43.9% |
| 2011 | $6.86M | +102.2% |
| 2010 | $3.39M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $722.4K | -6.0% | +25.8% |
| July 31, 2025 | $574.3K | -9.6% | -29.9% |
| April 30, 2025 | $818.7K | +32.4% | +6.6% |
| January 31, 2025 | $768.1K | +43.4% | +20.9% |
| July 31, 2024 | $635.4K | -59.0% | +2.7% |
| April 30, 2024 | $618.5K | -54.1% | +15.5% |
| January 31, 2024 | $535.6K | -56.8% | -65.4% |
| July 31, 2023 | $1.55M | +18.1% | +15.1% |
- Pharma-Bio Serv, Inc. showed an increase of +15.7% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2025 period, Pharma-Bio Serv, Inc.’s gross profit has declined by 14.2% (from $3.39 million to $2.91 million).
- The most recent figure is from Pharma-Bio Serv, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 29, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: